Zilia's innovative retinal camera, the Zilia Ocular FC, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), marking a pivotal moment in the company's growth.

"Receiving this first FDA clearance for our retinal camera is not just a milestone, it's a leap forward in our quest to safeguard the vision of millions," said Dr. Patrick Sauvageau, optometrist, CEO, and co-founder of Zilia. "We're now focused on obtaining De Novo classification for ocular oximetry, a breakthrough biomarker that promises to revolutionize how we diagnose and manage a variety of ocular conditions."